4D Molecular Therapeutics, Inc. (FDMT)
FDMT moved a median of -0.10% 30 minutes after news, and -0.37% by the close. How FDMT actually reacts to news — the realized, point-in-time move the market made, measured across 458 labeled events over the last three years with zero look-ahead.
FDMT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.03% | 50% | 456 |
| 30-min | -0.10% | 44% | 457 |
| 60-min | -0.12% | 47% | 457 |
| to close | -0.37% | 44% | 457 |
| Middle 50% of FDMT reactions | -1.55% to +1.25% |
|---|---|
| Median reaction (30-min) | -0.10% |
| Measured reactions | 458 |
Half of all 4D Molecular Therapeutics, Inc. news events land between -1.55% and +1.25% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How FDMT reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 11 | +0.81% | 64% | +0.88% |
| Coverage initiations | 18 | -2.12% | 28% | -3.42% |
| Rating reiterations | 93 | -0.20% | 44% | +0.20% |
| Price-target cuts | 13 | -1.01% | 31% | -4.03% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how FDMT ranks against every other measured name →
That’s how FDMT usually reacts — get an email when it moves on news →Email me when FDMT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to FDMT's baseline. Nothing else.
Recent FDMT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | +1.70% | — | |
| 4DMT to Host Investor Day on October 21, 2026 | Press release | GlobeNewswire | -2.02% | -6.78% | |
| 4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME | Press release | GlobeNewswire | -0.80% | +0.62% | |
| Form 8-K 4D Molecular Therapeutic For: Sep 28 | SEC filing · Form 8-K | SEC EDGAR | -0.80% | +0.62% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | -1.14% | +0.88% | |
| 4DMT to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +1.66% | +0.19% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | +1.07% | +19.22% | |
| 4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones | Press release | GlobeNewswire | -1.80% | +4.82% | |
| Form 10-Q 4D Molecular Therapeutic For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.80% | +4.82% | |
| Form 8-K 4D Molecular Therapeutic For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -1.80% | +4.82% | |
| Form 8-K 4D Molecular Therapeutic For: Jul 18 | SEC filing · Form 8-K | SEC EDGAR | +0.55% | +1.93% | |
| 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population | Press release | GlobeNewswire | +0.55% | +1.93% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | +0.55% | +1.93% | |
| 4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists | Press release | GlobeNewswire | -0.98% | -4.23% | |
| 4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD | Press release | GlobeNewswire | +1.03% | +10.27% | |
| 4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital | Press release | GlobeNewswire | +1.03% | +10.27% | |
| Form 8-K 4D Molecular Therapeutic For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +1.03% | +10.27% | |
| Form 8-K 4D Molecular Therapeutic For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | +2.64% | +13.50% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | +0.55% | +1.99% | |
| 4DMT to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -0.17% | +0.23% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | +0.33% | -8.18% | |
| Form EFFECT 4D Molecular Therapeutic | SEC filing · Form EFFECT | SEC EDGAR | -1.76% | -6.48% | |
| 4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones | Press release | GlobeNewswire | +5.12% | +11.67% | |
| Form 10-Q 4D Molecular Therapeutic For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +5.12% | +11.67% | |
| Form 8-K 4D Molecular Therapeutic For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +5.12% | +11.67% | |
| Form S-3 4D Molecular Therapeutic | SEC filing · Form S-3 | SEC EDGAR | +5.12% | +11.67% | |
| 4DMT to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +1.32% | +3.74% | |
| Form ARS 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.86% | -5.47% | |
| Form DEF 14A 4D Molecular Therapeutic For: Jun 17 | SEC filing · Form DEF | SEC EDGAR | +0.86% | -5.47% | |
| Form DEFA14A 4D Molecular Therapeutic | SEC filing · Form DEFA14A | SEC EDGAR | +0.86% | -5.47% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | -0.67% | -3.36% | |
| Form 8-K 4D Molecular Therapeutic For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | +4.10% | +5.92% | |
| 4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones | Press release | GlobeNewswire | -10.56% | -9.66% | |
| Form 10-K 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -10.56% | -9.66% | |
| Form 8-K 4D Molecular Therapeutic For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | -10.56% | -9.66% | |
| Form S-8 4D Molecular Therapeutic | SEC filing · Form S-8 | SEC EDGAR | -10.56% | -9.66% | |
| 4DMT to Participate in Upcoming Investor Meetings | Press release | GlobeNewswire | +1.13% | +0.47% | |
| 4DMT to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +0.88% | +0.55% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | +1.37% | -0.21% | |
| 4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD | Press release | GlobeNewswire | -0.79% | +1.79% | |
| Form 8-K 4D Molecular Therapeutic For: Jan 22 | SEC filing · Form 8-K | SEC EDGAR | +1.26% | +6.79% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | -0.34% | +3.67% | |
| 4DMT Provides Company Update and Anticipated Development Milestones for 2026 | Press release | GlobeNewswire | +1.10% | +6.58% | |
| Form 8-K 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form 8-K | SEC EDGAR | +1.10% | +6.58% | |
| 4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease | Press release | GlobeNewswire | -0.35% | -19.91% | |
| 4DMT Announces New Employment Inducement Grants | Press release | GlobeNewswire | +0.82% | +0.00% | |
| Form 8-K 4D Molecular Therapeutic For: Dec 10 | SEC filing · Form 8-K | SEC EDGAR | +1.01% | +0.00% | |
| 4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | +1.65% | +1.47% | |
| 4DMT to Participate in 8th Annual Evercore Healthcare Conference | Press release | GlobeNewswire | +0.91% | -6.00% | |
| 4DMT Appoints Kristian Humer as Chief Financial Officer | Press release | GlobeNewswire | +1.89% | +3.40% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the FDMT section they belong to.
Where else FDMT is measured.
FDMT earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is 4D Molecular Therapeutics, Inc.'s median reaction calculated?
Every labeled FDMT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 458 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of FDMT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does FDMT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.